TUMOR-NECROSIS-FACTOR-ALPHA IN SERUM OF MACAQUES DURING SIVMAC251 ACUTE INFECTION

被引:10
作者
CLAYETTE, P
LEGRAND, R
NOACK, O
VASLIN, B
LENAOUR, R
BENVENISTE, O
THEODORO, F
FRETIER, P
DORMONT, D
机构
[1] Laboratoire de Neuropathologie expérimentale et Neurovirologie, CEA, DSV, DPTE, SSA, Institut Paris-Sud sur les Cytokines, Fontenay Aux Roses
关键词
CYTOKINE; INFLAMMATION; ANIMAL MODEL; SIMIAN IMMUNODEFICIENCY VIRUS;
D O I
10.1111/j.1600-0684.1995.tb00152.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
TNF secretion was explored in sera during acute SIV-infection of cynomolgus macaques. A peak of TNF was detected in sera of animals in concomitance with SIV replication. Likewise, AZT treatment delayed acid reduced peaks of viral replication and TNF production. Thus, SIVmac251-infected monkey could be an excellent model to explore the interdigitation existing between HIV and TNF in acute and chronic infection and to develop new therapeutic strategies that target the production of this cytokine or its inductive effects.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
[1]   QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, IMMUNE ACTIVATION FACTORS, AND QUINOLINIC ACID IN AIDS BRAINS [J].
ACHIM, CL ;
HEYES, MP ;
WILEY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2769-2775
[2]  
BARRESINOUSSI F, 1983, SCIENCE, V200, P868
[3]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[4]  
BOTTIGER D, 1992, ANTIVIR CHEM CHEMOTH, V3, P267
[5]   PREVENTION OF HIV-2 AND SIV INFECTIONS IN CYNOMOLGUS MACAQUES BY PROPHYLACTIC TREATMENT WITH 3'-FLUOROTHYMIDINE [J].
BOTTIGER, D ;
PUTKONEN, P ;
OBERG, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (07) :1235-1238
[6]   EFFECTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN ON THE EXPRESSION OF INFLAMMATORY CYTOKINES [J].
BUONAGURO, L ;
BARILLARI, G ;
CHANG, HK ;
BOHAN, CA ;
KAO, V ;
MORGAN, R ;
GALLO, RC ;
ENSOLI, B .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7159-7167
[7]   CYTOKINES IN THE PATHOGENESIS AND MANAGEMENT OF NON-HODGKINS-LYMPHOMAS [J].
CICCO, NA ;
LUBBERT, M ;
OSTER, W ;
LINDEMANN, A ;
MERTELSMANN, R .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (05) :1053-1066
[8]  
CLOUSE KA, 1989, J IMMUNOL, V143, P470
[9]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431
[10]  
DANIEL MD, 1985, SCIENCE, V228, P1200